Koch Institute Luria Auditorium (76-156) and Zoom (see below for full information)
Suppression of the Ubiquitin Ligase Function of FBXW7 Accelerates Metastatic Progression of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal common malignancy because it is usually diagnosed at an advanced/metastatic stage. Dysregulation of protein stability and degradation has been associated with uncontrolled proliferation and genomic instability, leading to cancer progression to metastasis. One of the major regulators of protein degradation is the tumor suppressor FBXW7, a substrate recognition domain of the SCF E3 ubiquitin ligase, frequently dysregulated in many cancers.
The function and clinical significance of FBXW7 in pancreatic cancer has been studied in some detail. Pancreatic cancer patients with low FBXW7 expression levels have poor probability of survival compared to patients with high FBXW7 expression levels. Furthermore, Fbxw7 mutations and loss cooperate with KrasG12D to accelerate PDAC formation with a high frequency, showing that Fbxw7 is an important tumor suppressor in Kras-driven pancreatic cancer. However, studies on the impact of Fbxw7 expression and its substrates in pancreatic cancer progression to metastasis remains poorly understood.
Here, we demonstrate that Fbxw7 loss accelerates progression and metastatic potential of pancreatic cancer in KrasG12D/+; Trp53-/- PDAC models, in immunocompromised and immunocompetent hosts. We explore the impact of different Fbxw7 mutants in tumorigenesis, where the hotspot mutant R465 recapitulates the phenotype seen in complete loss-of-function of Fbxw7. Finally, we looked at global proteomic changes when Fbxw7 is lost to better understand mechanistically the role of Fbxw7 in PDAC progression to metastasis. This study addresses novel facets of PDAC metastasis which has the potential to identify novel therapeutic strategies for advanced and metastatic disease.
Tyler Jacks, PhD
David H. Koch Professor of Biology at MIT, Intramural Faculty, Koch Institute; Daniel K. Ludwig Scholar for Cancer Research, MIT
Thesis Committee Chair:
Richard Hynes, PhD
David H. Koch Professor of Biology at MIT, Intramural Faculty, Koch Institute; Daniel K. Ludwig Scholar, Howard Hughes Medical Institute Investigator
Alex K. Shalek, PhD
Associate Professor of Chemistry MIT, Core member of the Institute for Medical Engineering & Science, Extramural Member, Koch Institute, Member of Ragon Institute, Broad Institute, HMS, MGH
Timothy Padera, PhD
Associate Professor of Radiation Oncology, MGH, HMS
Zoom invitation –
Grissel Cervantes is inviting you to a scheduled Zoom meeting.
Topic: Grissel Cervantes MEMP PhD Thesis Defense
Time: Friday, September 23, 2022 2:30 PM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu, at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
One tap mobile
+16465588656,,98488702962# US (New York)
+16699006833,,98488702962# US (San Jose)
Meeting ID: 984 8870 2962
US: +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/aArhLfLMu
Join by SIP
98488702962 [at] zoomcrc.com
Join by Skype for Business